Immunomodulatory properties of transmembrane mucins: from chronic diseases to cancer
| dc.contributor.author | Montero, Paula | |
| dc.contributor.author | Roger Laparra, Inés | |
| dc.contributor.author | Milara, Javier | |
| dc.contributor.author | Cortijo, Julio | |
| dc.date.accessioned | 2026-08-07T10:38:48Z | |
| dc.date.available | 2026-08-07T10:38:48Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Mucins are large glycoproteins that form the primary structural component of mucus and can be classified intosecreted and transmembrane types. Of the 22 identified mucin genes, 12 encode transmembrane mucins, whichplay crucial roles in maintaining epithelial barrier integrity, modulating cell signaling, and innate immuneresponses to pathogens. Transmembrane mucins are expressed in epithelial cells, inflammatory cells, endothe-lial cells, and fibroblasts, influencing diverse cellular processes. They interact with extracellular ligands andtransduce intracellular signals, functioning as membrane receptors with cell type-specific effects, triggering anti-inflammatory, proliferative, fibrotic, or carcinogenic processes. | en |
| dc.description.filiation | UEV | |
| dc.description.impact | 35.7 Q1 JCR 2025 | spa |
| dc.description.impact | 11.493 Q1 SJR 2025 | spa |
| dc.description.impact | No data IDR 2024 | spa |
| dc.description.sponsorship | ID2020-114871RB-I00 | |
| dc.description.sponsorship | PI24/00169 | |
| dc.description.sponsorship | CD23/00192 | |
| dc.description.sponsorship | CB06/06/0027 | |
| dc.description.sponsorship | CIGE-2023-171 | |
| dc.identifier.citation | Montero, P., Roger, I., Milara, J., & Cortijo, J. (2025). Immunomodulatory properties of transmembrane mucins: From chronic diseases to cancer. Physiological Reviews, 105(4), 2233-2304. https://doi.org/10.1152/physrev.00034.2024 | |
| dc.identifier.doi | 10.1152/physrev.00034.2024 | |
| dc.identifier.issn | 0031-9333 | |
| dc.identifier.issn | 1522-1210 | |
| dc.identifier.uri | https://hdl.handle.net/11268/17366 | |
| dc.language.iso | eng | |
| dc.peerreviewed | Si | |
| dc.relation.publisherversion | https://doi.org/10.1152/physrev.00034.2024 | |
| dc.rights | Attribution-NoDerivatives 4.0 International | en |
| dc.rights.accessRights | open access | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nd/4.0/ | |
| dc.subject.other | Agentes Inmunomoduladores | |
| dc.subject.other | Enfermedad Crónica | |
| dc.subject.other | Mucinas | |
| dc.subject.sdg | Goal 3: Ensure healthy lives and promote well-being for all at all ages | |
| dc.subject.unesco | Farmacología | |
| dc.subject.unesco | Cáncer | |
| dc.subject.unesco | Investigación médica | |
| dc.title | Immunomodulatory properties of transmembrane mucins: from chronic diseases to cancer | en |
| dc.type | journal article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 8. Review Physiological review.pdf
- Size:
- 11.99 MB
- Format:
- Adobe Portable Document Format

